Search
Sumario de resultados
TIpos de contenido
Fecha
-
NewMikrobiomik receives the "Novel Company" award, granted by El Correo and Banco Sabadell
El lunes 20 de febrero, la compañía fue galardonada con el premio “Empresa Novel”, dentro de la entrega Premios Euskadi Avanza, y organizados por el periódico local de mayor importancia El Correo y el
-
NewORYZON Hosting Key Opinion Leader Webinar on Targeting Lysine Specific Demethylase 1 (LSD1...
Oryzon Genomics, announced today that it will host a virtual panel discussion, featuring Dr. Dyanna Phillips Domilici (Adams Clinical & Copley Clinical), Dr. med. Peter Hahn (Investigator & Neurology
-
New#NewMember | "A leading organization in terms of innovation which promotes collaboration a...
Meet CEISA, our new member. We talked to Josep Tascón, CEO of the company.
-
NewBCN HEALTH publishes a study reviewing economic evaluations and burden of disease studies ...
BCN HEALTH ha publicado el estudio 'Economic implications of endometriosis: A review' en la revista 'PharmacoEconomics'
-
-
-
-
-
AllyMontero Language Services
We are a company with 20 years of experience, offering a specialized translation service for Life Science industry among others. With the help of our multilingual team of more than 50 highly
-
-
OfferData Engineer
-
NewCash, cash equivalents and marketable securities totaled $22.7 million as of December 31, ...
Strong clinical progress in both oncology and CNS
-
-
-
-
-
Press release
AseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere
The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the
-
NewAseBio showcases strategic capacity of Spanish biotechnology industry at Transfiere
The forum is held in Malaga with over 3,000 professionals from the science and innovation sector. AseBio is displaying innovative bioproducts from over a dozen member companies that are tackling the
-
NewTelum Therapeutics names Vincent A. Fischetti chairman of its Scientific Advisory Board
Professor Vincent A. Fischetti is the inventor of phage lysins as a new therapeutic and an alternative to conventional antibiotics
-
NewAsabys announces the first close of its fund, with commitments of €100M, and appoints Sylv...
Banco Sabadell stands as the firm’s main private institutional investor, like in its previous fund in 2018. Other Investors include the European Investment Fund and Alantra
-
